B. Ronan

发表

In Vitro Characterization of VPS34 Lipid Kinase Inhibition by Small Molecules.

M. Mathieu, B. Pasquier, N. Michot, 2017, Methods in enzymology.

Identifying Small Molecules which Inhibit Autophagy: a Phenotypic Screen Using Image-Based High-Content Cell Analysis

C. Rugg, B. Pasquier, L. Durand, 2014, Current chemical genomics and translational medicine.

Asymmetric oxidation of some 1,3-dithianes in presence of chiral titanium complexes☆

H. Kagan, O. Samuel, B. Ronan, 1989 .

Highly enantioselective synthesis of a Corey prostaglandin intermediate

H. Kagan, B. Ronan, 1992 .

From PtCl(2)- and acid-catalyzed to uncatalyzed cycloisomerization of 2-propargyl anilines: access to functionalized indoles.

S. Mignani, L. Fensterbank, M. Malacria, 2007, Angewandte Chemie.

Synthesis of optically active amino azapenams by the photolytic reaction of chromium aminocarbene complexes with N-protected imidazolines

L. Hegedus, B. Ronan, 1993 .

Asymmetric additions of α-sulfoxide carbanion on imines

H. Kagan, O. Samuel, B. Ronan, 1988 .

17-diazo pristinamycin IIB preparation and synthetic applications

E. Bacqué, J. Barrière, B. Ronan, 2004 .

Preparation of 14,36-didehydro pristinamycins IIs

E. Bacqué, J. Barrière, S. Sablé, 2003 .

Highly Enantioselective Synthesis of a Corey Prostaglandin Intermediate.

H. Kagan, B. Ronan, 1992 .

Highly diastereoselective Diels-Alder reactions with (R)-ethoxy p-tolyl vinyl sulfonium tetrafluoroborate

H. Kagan, B. Ronan, 1991 .

Design and synthesis of a prototype model antagonist of tachykinin NK-2 receptor

S. Hanessian, A. Laoui, B. Ronan, 1994 .

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Jean-Pierre Marquette, Magali Mathieu, Thomas Bertrand, 2014, Nature chemical biology.

From PtCl2- and Acid-Catalyzed to Uncatalyzed Cycloisomerization of 2-Propargyl Anilines: Access to Functionalized Indoles.

S. Mignani, L. Fensterbank, M. Malacria, 2007 .

Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors.

M. Mathieu, C. García-echeverría, F. Gay, 2014, Journal of medicinal chemistry.

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

M. Mathieu, C. García-echeverría, B. Pasquier, 2014, Nature chemical biology.